PMID- 28912194 OWN - NLM STAT- MEDLINE DCOM- 20180522 LR - 20221207 IS - 2044-6055 (Electronic) IS - 2044-6055 (Linking) VI - 7 IP - 9 DP - 2017 Sep 14 TI - Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. PG - e016317 LID - 10.1136/bmjopen-2017-016317 [doi] LID - e016317 AB - OBJECTIVES: The disease burden of type 2 diabetes mellitus (T2DM) is rising due to suboptimal glycaemic control leading to vascular complications. Medication adherence (MA) directly influences glycaemic control and clinical consequences. This study aimed to assess the MA of patients with T2DM and identify associated factors. DESIGN: Analysis of data from a cross-sectional survey and electronic medical records. SETTING: Primary care outpatient clinic in Singapore. PARTICIPANTS: Adult patients with T2DM. MAIN OUTCOME MEASURES: MA to each prescribed oral hypoglycaemic agent (OHA) was measured using the five-question Medication Adherence Report Scale (MARS-5). Low MA is defined as a MARS-R score of <25. Demographic data, clinical characteristics and investigation results were collected to identify factors that are associated with low MA. RESULTS: The study population comprised 382 patients with a slight female predominance (53.4%) and a mean+/-SD age of 62.0+/-10.4 years. 57.1% of the patients had low MA to at least one OHA. Univariate analysis showed that patients who were younger, of Chinese ethnicity, married or widowed, self-administering their medications or taking fewer (four or less) daily medications tended to have low MA to OHA. Logistic regression revealed that younger age (OR 0.97; 95% CI 0.95 to0.99), Chinese ethnicity (OR 2.80; 95% CI 1.53 to5.15) and poorer glycaemic control (HbA1c level) (OR 1.27; 95% CI 1.06 to1.51) were associated with low MA to OHA. CONCLUSIONS: Younger patients with T2DM and of Chinese ethnicity were susceptible to low MA to OHA, which was associated with poorer glycaemic control. Polytherapy was not associated with low MA. CI - (c) Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. FAU - Lee, Cia Sin AU - Lee CS AD - SingHealth Polyclinics, Singapore, Singapore. FAU - Tan, Jane Hwee Mian AU - Tan JHM AD - SingHealth Polyclinics, Singapore, Singapore. FAU - Sankari, Usha AU - Sankari U AD - SingHealth Polyclinics, Singapore, Singapore. FAU - Koh, Yi Ling Eileen AU - Koh YLE AD - SingHealth Polyclinics, Singapore, Singapore. FAU - Tan, Ngiap Chuan AU - Tan NC AD - SingHealth Polyclinics, Singapore, Singapore. AD - Duke-NUS Medical School, Singapore, Singapore. LA - eng PT - Journal Article DEP - 20170914 PL - England TA - BMJ Open JT - BMJ open JID - 101552874 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) SB - IM MH - Age Factors MH - Aged MH - *Asian People MH - Blood Glucose/*metabolism MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/*drug therapy/ethnology/therapy MH - *Ethnicity MH - Female MH - Glycated Hemoglobin/metabolism MH - Humans MH - Hypoglycemic Agents/*therapeutic use MH - Logistic Models MH - Male MH - *Medication Adherence MH - Middle Aged MH - Odds Ratio MH - Singapore PMC - PMC5640112 OTO - NOTNLM OT - medication adherence OT - oral hypoglycemic agent OT - polytherapy OT - type 2 diabetes mellitus COIS- Competing interests: None declared. EDAT- 2017/09/16 06:00 MHDA- 2018/05/23 06:00 PMCR- 2017/09/14 CRDT- 2017/09/16 06:00 PHST- 2017/09/16 06:00 [entrez] PHST- 2017/09/16 06:00 [pubmed] PHST- 2018/05/23 06:00 [medline] PHST- 2017/09/14 00:00 [pmc-release] AID - bmjopen-2017-016317 [pii] AID - 10.1136/bmjopen-2017-016317 [doi] PST - epublish SO - BMJ Open. 2017 Sep 14;7(9):e016317. doi: 10.1136/bmjopen-2017-016317.